The FDA has granted retatrutide Fast Track designation, but as of January 2025 no phase 3 obesity or diabetes trial has reported primary outcomes [2]
Eli Lilly also has a pill version waiting in the wings that promises to be just as effective as semaglutide, precipitating a drop in the Danish companys stock, which has never rebounded to its $615 billion peak in market capitalization nearly two years ago
The absence of effects on IGF-1, glucose metabolism, and tissue growth reduces concerns about long-term hormonal consequences, but prudent medical oversight remains appropriate for any extended peptide use
A clinical trial published in 2022 found that an older GLP-1 drug called exenatide also reduced drinking among those who had both alcohol use disorder and obesity
Reddys on April 28, Apotex on May 1) and is reviewing seven more submissions Filed Under: Metabolic disease/endicrinology, Uncategorized
Naringenin is a flavonoid compound that is abundant in grapefruit, orange and tomato peels, has antioxidant properties [86] and is a potent neuroprotective through its direct or indirect effect on various pathological pathways